source name	characteristics[organism]	characteristics[organism part]	characteristics[disease]	characteristics[cell type]	characteristics[cell line]	characteristics[biological replicate]	assay name	technology type	comment[label]	comment[data file]	comment[file uri]	comment[technical replicate]	comment[fraction identifier]	comment[cleavage agent details]	comment[instrument]	comment[modification parameters]	comment[modification parameters]	comment[proteomics data acquisition method]	comment[fractionation method]	comment[dissociation method]	comment[precursor mass tolerance]	comment[fragment mass tolerance]	comment[collision energy]	factor value[cell line]
PXD003539-Sample 1	Homo sapiens	not available	Acute lymphoblastic leukemia ALL	not available	CCRF-CEM	1	run 1	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	guot_L130610_003_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130610_003_SW.wiff	1	1	NT=Trypsin;AC=MS:1001251	NT=TripleTOF 5600;AC=MS:1000932	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=High-performance liquid chromatography;AC=PRIDE:0000565	NT=HCD;AC=PRIDE:0000590	5 ppm	0.1 Da	30% NCE	CCRF-CEM
PXD003539-Sample 1	Homo sapiens	not available	Acute lymphoblastic leukemia ALL	not available	CCRFCEM	1	run 2	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	guot_L130622_002_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130622_002_SW.wiff	2	1	NT=Trypsin;AC=MS:1001251	NT=TripleTOF 5600;AC=MS:1000932	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=High-performance liquid chromatography;AC=PRIDE:0000565	NT=HCD;AC=PRIDE:0000590	5 ppm	0.1 Da	30% NCE	CCRFCEM
PXD003539-Sample 2	Homo sapiens	not available	Lung adenocarcinoma	not available	EKVX	1	run 3	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	guot_L130610_004_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130610_004_SW.wiff	1	1	NT=Trypsin;AC=MS:1001251	NT=TripleTOF 5600;AC=MS:1000932	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=High-performance liquid chromatography;AC=PRIDE:0000565	NT=HCD;AC=PRIDE:0000590	5 ppm	0.1 Da	30% NCE	EKVX
PXD003539-Sample 2	Homo sapiens	not available	Lung adenocarcinoma	not available	EKVX	1	run 4	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	guot_L130622_003_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130622_003_SW.wiff	2	1	NT=Trypsin;AC=MS:1001251	NT=TripleTOF 5600;AC=MS:1000932	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=High-performance liquid chromatography;AC=PRIDE:0000565	NT=HCD;AC=PRIDE:0000590	5 ppm	0.1 Da	30% NCE	EKVX
PXD003539-Sample 3	Homo sapiens	not available	colorectal carcinoma	not available	HCT116	1	run 5	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	guot_L130610_005_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130610_005_SW.wiff	1	1	NT=Trypsin;AC=MS:1001251	NT=TripleTOF 5600;AC=MS:1000932	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=High-performance liquid chromatography;AC=PRIDE:0000565	NT=HCD;AC=PRIDE:0000590	5 ppm	0.1 Da	30% NCE	HCT116
PXD003539-Sample 3	Homo sapiens	not available	colorectal carcinoma	not available	HCT116	1	run 6	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	guot_L130622_004_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130622_004_SW.wiff	2	1	NT=Trypsin;AC=MS:1001251	NT=TripleTOF 5600;AC=MS:1000932	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=High-performance liquid chromatography;AC=PRIDE:0000565	NT=HCD;AC=PRIDE:0000590	5 ppm	0.1 Da	30% NCE	HCT116
PXD003539-Sample 4	Homo sapiens	not available	Ovarian Cancer	not available	IGROV-1	1	run 7	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	guot_L130610_006_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130610_006_SW.wiff	1	1	NT=Trypsin;AC=MS:1001251	NT=TripleTOF 5600;AC=MS:1000932	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=High-performance liquid chromatography;AC=PRIDE:0000565	NT=HCD;AC=PRIDE:0000590	5 ppm	0.1 Da	30% NCE	IGROV-1
PXD003539-Sample 4	Homo sapiens	not available	Ovarian Cancer	not available	IGROV-1	1	run 8	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	guot_L130622_005_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130622_005_SW.wiff	2	1	NT=Trypsin;AC=MS:1001251	NT=TripleTOF 5600;AC=MS:1000932	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=High-performance liquid chromatography;AC=PRIDE:0000565	NT=HCD;AC=PRIDE:0000590	5 ppm	0.1 Da	30% NCE	IGROV-1
PXD003539-Sample 5	Homo sapiens	not available	Renal Adenocarcinoma	not available	RXF393	1	run 9	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	guot_L130611_007_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130611_007_SW.wiff	1	1	NT=Trypsin;AC=MS:1001251	NT=TripleTOF 5600;AC=MS:1000932	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=High-performance liquid chromatography;AC=PRIDE:0000565	NT=HCD;AC=PRIDE:0000590	5 ppm	0.1 Da	30% NCE	RXF393
PXD003539-Sample 5	Homo sapiens	not available	Renal Adenocarcinoma	not available	RXF393	1	run 10	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	guot_L130622_006_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130622_006_SW.wiff	2	1	NT=Trypsin;AC=MS:1001251	NT=TripleTOF 5600;AC=MS:1000932	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=High-performance liquid chromatography;AC=PRIDE:0000565	NT=HCD;AC=PRIDE:0000590	5 ppm	0.1 Da	30% NCE	RXF393
PXD003539-Sample 6	Homo sapiens	not available	Renal Adenocarcinoma	not available	Caki-1	1	run 11	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	guot_L130611_010_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130611_010_SW.wiff	1	1	NT=Trypsin;AC=MS:1001251	NT=TripleTOF 5600;AC=MS:1000932	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=High-performance liquid chromatography;AC=PRIDE:0000565	NT=HCD;AC=PRIDE:0000590	5 ppm	0.1 Da	30% NCE	Caki-1
PXD003539-Sample 6	Homo sapiens	not available	Renal Adenocarcinoma	not available	Caki-1	1	run 12	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	guot_L130623_002_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130623_002_SW.wiff	2	1	NT=Trypsin;AC=MS:1001251	NT=TripleTOF 5600;AC=MS:1000932	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=High-performance liquid chromatography;AC=PRIDE:0000565	NT=HCD;AC=PRIDE:0000590	5 ppm	0.1 Da	30% NCE	Caki-1
PXD003539-Sample 7	Homo sapiens	not available	Colorectal carcinoma	not available	KM12	1	run 13	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	guot_L130611_011_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130611_011_SW.wiff	1	1	NT=Trypsin;AC=MS:1001251	NT=TripleTOF 5600;AC=MS:1000932	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=High-performance liquid chromatography;AC=PRIDE:0000565	NT=HCD;AC=PRIDE:0000590	5 ppm	0.1 Da	30% NCE	KM12
PXD003539-Sample 7	Homo sapiens	not available	Colorectal carcinoma	not available	KM12	1	run 14	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	guot_L130623_003_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130623_003_SW.wiff	2	1	NT=Trypsin;AC=MS:1001251	NT=TripleTOF 5600;AC=MS:1000932	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=High-performance liquid chromatography;AC=PRIDE:0000565	NT=HCD;AC=PRIDE:0000590	5 ppm	0.1 Da	30% NCE	KM12
PXD003539-Sample 8	Homo sapiens	not available	Brain Cancer	not available	SF539	1	run 15	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	guot_L130611_012_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130611_012_SW.wiff	1	1	NT=Trypsin;AC=MS:1001251	NT=TripleTOF 5600;AC=MS:1000932	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=High-performance liquid chromatography;AC=PRIDE:0000565	NT=HCD;AC=PRIDE:0000590	5 ppm	0.1 Da	30% NCE	SF539
PXD003539-Sample 8	Homo sapiens	not available	Brain Cancer	not available	SF539	1	run 16	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	guot_L130623_004_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130623_004_SW.wiff	2	1	NT=Trypsin;AC=MS:1001251	NT=TripleTOF 5600;AC=MS:1000932	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=High-performance liquid chromatography;AC=PRIDE:0000565	NT=HCD;AC=PRIDE:0000590	5 ppm	0.1 Da	30% NCE	SF539
PXD003539-Sample 9	Homo sapiens	not available	Malignant Melanoma	not available	SK-MEL-2	1	run 17	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	guot_L130611_013_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130611_013_SW.wiff	1	1	NT=Trypsin;AC=MS:1001251	NT=TripleTOF 5600;AC=MS:1000932	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=High-performance liquid chromatography;AC=PRIDE:0000565	NT=HCD;AC=PRIDE:0000590	5 ppm	0.1 Da	30% NCE	SK-MEL-2
PXD003539-Sample 9	Homo sapiens	not available	Malignant Melanoma	not available	SK-MEL-2	1	run 18	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	guot_L130623_005_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130623_005_SW.wiff	2	1	NT=Trypsin;AC=MS:1001251	NT=TripleTOF 5600;AC=MS:1000932	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=High-performance liquid chromatography;AC=PRIDE:0000565	NT=HCD;AC=PRIDE:0000590	5 ppm	0.1 Da	30% NCE	SK-MEL-2
PXD003539-Sample 10	Homo sapiens	not available	Ovarian Cancer	not available	SK-OV-3	1	run 19	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	guot_L130611_014_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130611_014_SW.wiff	1	1	NT=Trypsin;AC=MS:1001251	NT=TripleTOF 5600;AC=MS:1000932	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=High-performance liquid chromatography;AC=PRIDE:0000565	NT=HCD;AC=PRIDE:0000590	5 ppm	0.1 Da	30% NCE	SK-OV-3
PXD003539-Sample 10	Homo sapiens	not available	Ovarian Cancer	not available	SK-OV-3	1	run 20	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	guot_L130623_006_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130623_006_SW.wiff	2	1	NT=Trypsin;AC=MS:1001251	NT=TripleTOF 5600;AC=MS:1000932	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=High-performance liquid chromatography;AC=PRIDE:0000565	NT=HCD;AC=PRIDE:0000590	5 ppm	0.1 Da	30% NCE	SK-OV-3
PXD003539-Sample 11	Homo sapiens	not available	Renal Adenocarcinoma	not available	786-O	1	run 21	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	guot_L130612_002_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130612_002_SW.wiff	1	1	NT=Trypsin;AC=MS:1001251	NT=TripleTOF 5600;AC=MS:1000932	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=High-performance liquid chromatography;AC=PRIDE:0000565	NT=HCD;AC=PRIDE:0000590	5 ppm	0.1 Da	30% NCE	786-O
PXD003539-Sample 11	Homo sapiens	not available	Renal Adenocarcinoma	not available	786-O	1	run 22	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	guot_L130624_002_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130624_002_SW.wiff	2	1	NT=Trypsin;AC=MS:1001251	NT=TripleTOF 5600;AC=MS:1000932	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=High-performance liquid chromatography;AC=PRIDE:0000565	NT=HCD;AC=PRIDE:0000590	5 ppm	0.1 Da	30% NCE	786-O
PXD003539-Sample 12	Homo sapiens	not available	colon adenocarcinoma	not available	HT-29	1	run 23	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	guot_L130612_003_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130612_003_SW.wiff	1	1	NT=Trypsin;AC=MS:1001251	NT=TripleTOF 5600;AC=MS:1000932	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=High-performance liquid chromatography;AC=PRIDE:0000565	NT=HCD;AC=PRIDE:0000590	5 ppm	0.1 Da	30% NCE	HT-29
PXD003539-Sample 12	Homo sapiens	not available	colon adenocarcinoma	not available	HT-29	1	run 24	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	guot_L130624_003_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130624_003_SW.wiff	2	1	NT=Trypsin;AC=MS:1001251	NT=TripleTOF 5600;AC=MS:1000932	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=High-performance liquid chromatography;AC=PRIDE:0000565	NT=HCD;AC=PRIDE:0000590	5 ppm	0.1 Da	30% NCE	HT-29
PXD003539-Sample 13	Homo sapiens	not available	Chronic Myelogenous Leukemia Cml	not available	K-562	1	run 25	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	guot_L130612_004_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130612_004_SW.wiff	1	1	NT=Trypsin;AC=MS:1001251	NT=TripleTOF 5600;AC=MS:1000932	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=High-performance liquid chromatography;AC=PRIDE:0000565	NT=HCD;AC=PRIDE:0000590	5 ppm	0.1 Da	30% NCE	K-562
PXD003539-Sample 13	Homo sapiens	not available	Chronic Myelogenous Leukemia Cml	not available	K-562	1	run 26	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	guot_L130624_004_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130624_004_SW.wiff	2	1	NT=Trypsin;AC=MS:1001251	NT=TripleTOF 5600;AC=MS:1000932	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=High-performance liquid chromatography;AC=PRIDE:0000565	NT=HCD;AC=PRIDE:0000590	5 ppm	0.1 Da	30% NCE	K-562
PXD003539-Sample 14	Homo sapiens	not available	Breast Cancer	not available	MDA-MB-231	1	run 27	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	guot_L130612_005_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130612_005_SW.wiff	1	1	NT=Trypsin;AC=MS:1001251	NT=TripleTOF 5600;AC=MS:1000932	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=High-performance liquid chromatography;AC=PRIDE:0000565	NT=HCD;AC=PRIDE:0000590	5 ppm	0.1 Da	30% NCE	MDA-MB-231
PXD003539-Sample 14	Homo sapiens	not available	Breast Cancer	not available	MDA-MB-231	1	run 28	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	guot_L130624_005_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130624_005_SW.wiff	2	1	NT=Trypsin;AC=MS:1001251	NT=TripleTOF 5600;AC=MS:1000932	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=High-performance liquid chromatography;AC=PRIDE:0000565	NT=HCD;AC=PRIDE:0000590	5 ppm	0.1 Da	30% NCE	MDA-MB-231
PXD003539-Sample 15	Homo sapiens	not available	Malignant Melanoma	not available	SK-MEL-5	1	run 29	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	guot_L130612_006_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130612_006_SW.wiff	1	1	NT=Trypsin;AC=MS:1001251	NT=TripleTOF 5600;AC=MS:1000932	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=High-performance liquid chromatography;AC=PRIDE:0000565	NT=HCD;AC=PRIDE:0000590	5 ppm	0.1 Da	30% NCE	SK-MEL-5
PXD003539-Sample 15	Homo sapiens	not available	Malignant Melanoma	not available	SK-MEL-5	1	run 30	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	guot_L130624_006_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130624_006_SW.wiff	2	1	NT=Trypsin;AC=MS:1001251	NT=TripleTOF 5600;AC=MS:1000932	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=High-performance liquid chromatography;AC=PRIDE:0000565	NT=HCD;AC=PRIDE:0000590	5 ppm	0.1 Da	30% NCE	SK-MEL-5
PXD003539-Sample 16	Homo sapiens	not available	Acute promyelocytic leukemia	not available	HL-60	1	run 31	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	guot_L130613_002_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130613_002_SW.wiff	1	1	NT=Trypsin;AC=MS:1001251	NT=TripleTOF 5600;AC=MS:1000932	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=High-performance liquid chromatography;AC=PRIDE:0000565	NT=HCD;AC=PRIDE:0000590	5 ppm	0.1 Da	30% NCE	HL-60
PXD003539-Sample 16	Homo sapiens	not available	Acute promyelocytic leukemia	not available	HL-60	1	run 32	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	guot_L130625_002_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130625_002_SW.wiff	2	1	NT=Trypsin;AC=MS:1001251	NT=TripleTOF 5600;AC=MS:1000932	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=High-performance liquid chromatography;AC=PRIDE:0000565	NT=HCD;AC=PRIDE:0000590	5 ppm	0.1 Da	30% NCE	HL-60
PXD003539-Sample 17	Homo sapiens	not available	Breast Cancer	not available	MCF7	1	run 33	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	guot_L130613_003_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130613_003_SW.wiff	1	1	NT=Trypsin;AC=MS:1001251	NT=TripleTOF 5600;AC=MS:1000932	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=High-performance liquid chromatography;AC=PRIDE:0000565	NT=HCD;AC=PRIDE:0000590	5 ppm	0.1 Da	30% NCE	MCF7
PXD003539-Sample 17	Homo sapiens	not available	Breast Cancer	not available	MCF7	1	run 34	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	guot_L130625_003_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130625_003_SW.wiff	2	1	NT=Trypsin;AC=MS:1001251	NT=TripleTOF 5600;AC=MS:1000932	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=High-performance liquid chromatography;AC=PRIDE:0000565	NT=HCD;AC=PRIDE:0000590	5 ppm	0.1 Da	30% NCE	MCF7
PXD003539-Sample 18	Homo sapiens	not available	Brain Cancer	not available	SF295	1	run 35	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	guot_L130613_004_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130613_004_SW.wiff	1	1	NT=Trypsin;AC=MS:1001251	NT=TripleTOF 5600;AC=MS:1000932	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=High-performance liquid chromatography;AC=PRIDE:0000565	NT=HCD;AC=PRIDE:0000590	5 ppm	0.1 Da	30% NCE	SF295
PXD003539-Sample 18	Homo sapiens	not available	Brain Cancer	not available	SF295	1	run 36	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	guot_L130625_004_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130625_004_SW.wiff	2	1	NT=Trypsin;AC=MS:1001251	NT=TripleTOF 5600;AC=MS:1000932	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=High-performance liquid chromatography;AC=PRIDE:0000565	NT=HCD;AC=PRIDE:0000590	5 ppm	0.1 Da	30% NCE	SF295
PXD003539-Sample 19	Homo sapiens	not available	Malignant Melanoma	not available	SK-MEL-28	1	run 37	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	guot_L130613_005_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130613_005_SW.wiff	1	1	NT=Trypsin;AC=MS:1001251	NT=TripleTOF 5600;AC=MS:1000932	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=High-performance liquid chromatography;AC=PRIDE:0000565	NT=HCD;AC=PRIDE:0000590	5 ppm	0.1 Da	30% NCE	SK-MEL-28
PXD003539-Sample 19	Homo sapiens	not available	Malignant Melanoma	not available	SK-MEL-28	1	run 38	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	guot_L130625_005_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130625_005_SW.wiff	2	1	NT=Trypsin;AC=MS:1001251	NT=TripleTOF 5600;AC=MS:1000932	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=High-performance liquid chromatography;AC=PRIDE:0000565	NT=HCD;AC=PRIDE:0000590	5 ppm	0.1 Da	30% NCE	SK-MEL-28
PXD003539-Sample 20	Homo sapiens	not available	Colorectal carcinoma	not available	SW620	1	run 39	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	guot_L130613_006_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130613_006_SW.wiff	1	1	NT=Trypsin;AC=MS:1001251	NT=TripleTOF 5600;AC=MS:1000932	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=High-performance liquid chromatography;AC=PRIDE:0000565	NT=HCD;AC=PRIDE:0000590	5 ppm	0.1 Da	30% NCE	SW620
PXD003539-Sample 20	Homo sapiens	not available	Colorectal carcinoma	not available	SW620	1	run 40	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	guot_L130625_006_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130625_006_SW.wiff	2	1	NT=Trypsin;AC=MS:1001251	NT=TripleTOF 5600;AC=MS:1000932	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=High-performance liquid chromatography;AC=PRIDE:0000565	NT=HCD;AC=PRIDE:0000590	5 ppm	0.1 Da	30% NCE	SW620
PXD003539-Sample 21	Homo sapiens	not available	Renal Adenocarcinoma	not available	A-498	1	run 41	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	guot_L130614_002_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130614_002_SW.wiff	1	1	NT=Trypsin;AC=MS:1001251	NT=TripleTOF 5600;AC=MS:1000932	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=High-performance liquid chromatography;AC=PRIDE:0000565	NT=HCD;AC=PRIDE:0000590	5 ppm	0.1 Da	30% NCE	A-498
PXD003539-Sample 21	Homo sapiens	not available	Renal Adenocarcinoma	not available	A-498	1	run 42	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	guot_L130626_002_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130626_002_SW.wiff	2	1	NT=Trypsin;AC=MS:1001251	NT=TripleTOF 5600;AC=MS:1000932	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=High-performance liquid chromatography;AC=PRIDE:0000565	NT=HCD;AC=PRIDE:0000590	5 ppm	0.1 Da	30% NCE	A-498
PXD003539-Sample 22	Homo sapiens	not available	Lung adenocarcinoma	not available	NCI-H322M	1	run 43	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	guot_L130614_003_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130614_003_SW.wiff	1	1	NT=Trypsin;AC=MS:1001251	NT=TripleTOF 5600;AC=MS:1000932	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=High-performance liquid chromatography;AC=PRIDE:0000565	NT=HCD;AC=PRIDE:0000590	5 ppm	0.1 Da	30% NCE	NCI-H322M
PXD003539-Sample 22	Homo sapiens	not available	Lung adenocarcinoma	not available	NCI-H322M	1	run 44	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	guot_L130626_003_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130626_003_SW.wiff	2	1	NT=Trypsin;AC=MS:1001251	NT=TripleTOF 5600;AC=MS:1000932	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=High-performance liquid chromatography;AC=PRIDE:0000565	NT=HCD;AC=PRIDE:0000590	5 ppm	0.1 Da	30% NCE	NCI-H322M
PXD003539-Sample 23	Homo sapiens	not available	Ovarian Cancer	not available	OVCAR8	1	run 45	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	guot_L130614_004_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130614_004_SW.wiff	1	1	NT=Trypsin;AC=MS:1001251	NT=TripleTOF 5600;AC=MS:1000932	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=High-performance liquid chromatography;AC=PRIDE:0000565	NT=HCD;AC=PRIDE:0000590	5 ppm	0.1 Da	30% NCE	OVCAR8
PXD003539-Sample 23	Homo sapiens	not available	Ovarian Cancer	not available	OVCAR8	1	run 46	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	guot_L130626_004_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130626_004_SW.wiff	2	1	NT=Trypsin;AC=MS:1001251	NT=TripleTOF 5600;AC=MS:1000932	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=High-performance liquid chromatography;AC=PRIDE:0000565	NT=HCD;AC=PRIDE:0000590	5 ppm	0.1 Da	30% NCE	OVCAR8
PXD003539-Sample 24	Homo sapiens	not available	Brain Cancer	not available	SNB19	1	run 47	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	guot_L130614_005_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130614_005_SW.wiff	1	1	NT=Trypsin;AC=MS:1001251	NT=TripleTOF 5600;AC=MS:1000932	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=High-performance liquid chromatography;AC=PRIDE:0000565	NT=HCD;AC=PRIDE:0000590	5 ppm	0.1 Da	30% NCE	SNB19
PXD003539-Sample 24	Homo sapiens	not available	Brain Cancer	not available	SNB19	1	run 48	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	guot_L130626_005_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130626_005_SW.wiff	2	1	NT=Trypsin;AC=MS:1001251	NT=TripleTOF 5600;AC=MS:1000932	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=High-performance liquid chromatography;AC=PRIDE:0000565	NT=HCD;AC=PRIDE:0000590	5 ppm	0.1 Da	30% NCE	SNB19
PXD003539-Sample 25	Homo sapiens	not available	Malignant Melanoma	not available	UACC-62	1	run 49	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	guot_L130614_006_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130614_006_SW.wiff	1	1	NT=Trypsin;AC=MS:1001251	NT=TripleTOF 5600;AC=MS:1000932	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=High-performance liquid chromatography;AC=PRIDE:0000565	NT=HCD;AC=PRIDE:0000590	5 ppm	0.1 Da	30% NCE	UACC-62
PXD003539-Sample 25	Homo sapiens	not available	Malignant Melanoma	not available	UACC-62	1	run 50	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	guot_L130626_006_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130626_006_SW.wiff	2	1	NT=Trypsin;AC=MS:1001251	NT=TripleTOF 5600;AC=MS:1000932	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=High-performance liquid chromatography;AC=PRIDE:0000565	NT=HCD;AC=PRIDE:0000590	5 ppm	0.1 Da	30% NCE	UACC-62
PXD003539-Sample 26	Homo sapiens	not available	Renal Adenocarcinoma	not available	ACHN	1	run 51	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	guot_L130615_002_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130615_002_SW.wiff	1	1	NT=Trypsin;AC=MS:1001251	NT=TripleTOF 5600;AC=MS:1000932	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=High-performance liquid chromatography;AC=PRIDE:0000565	NT=HCD;AC=PRIDE:0000590	5 ppm	0.1 Da	30% NCE	ACHN
PXD003539-Sample 26	Homo sapiens	not available	Renal Adenocarcinoma	not available	ACHN	1	run 52	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	guot_L130627_002_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130627_002_SW.wiff	2	1	NT=Trypsin;AC=MS:1001251	NT=TripleTOF 5600;AC=MS:1000932	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=High-performance liquid chromatography;AC=PRIDE:0000565	NT=HCD;AC=PRIDE:0000590	5 ppm	0.1 Da	30% NCE	ACHN
PXD003539-Sample 27	Homo sapiens	not available	Malignant Melanoma	not available	Malme-3M	1	run 53	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	guot_L130615_003_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130615_003_SW.wiff	1	1	NT=Trypsin;AC=MS:1001251	NT=TripleTOF 5600;AC=MS:1000932	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=High-performance liquid chromatography;AC=PRIDE:0000565	NT=HCD;AC=PRIDE:0000590	5 ppm	0.1 Da	30% NCE	Malme-3M
PXD003539-Sample 27	Homo sapiens	not available	Malignant Melanoma	not available	Malme-3M	1	run 54	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	guot_L130627_003_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130627_003_SW.wiff	2	1	NT=Trypsin;AC=MS:1001251	NT=TripleTOF 5600;AC=MS:1000932	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=High-performance liquid chromatography;AC=PRIDE:0000565	NT=HCD;AC=PRIDE:0000590	5 ppm	0.1 Da	30% NCE	Malme-3M
PXD003539-Sample 28	Homo sapiens	not available	Ovarian Cancer	not available	OVCAR4	1	run 55	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	guot_L130615_004_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130615_004_SW.wiff	1	1	NT=Trypsin;AC=MS:1001251	NT=TripleTOF 5600;AC=MS:1000932	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=High-performance liquid chromatography;AC=PRIDE:0000565	NT=HCD;AC=PRIDE:0000590	5 ppm	0.1 Da	30% NCE	OVCAR4
PXD003539-Sample 28	Homo sapiens	not available	Ovarian Cancer	not available	OVCAR4	1	run 56	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	guot_L130627_004_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130627_004_SW.wiff	2	1	NT=Trypsin;AC=MS:1001251	NT=TripleTOF 5600;AC=MS:1000932	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=High-performance liquid chromatography;AC=PRIDE:0000565	NT=HCD;AC=PRIDE:0000590	5 ppm	0.1 Da	30% NCE	OVCAR4
PXD003539-Sample 29	Homo sapiens	not available	Plasmacytoma	not available	RPMI 8226	1	run 57	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	guot_L130615_005_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130615_005_SW.wiff	1	1	NT=Trypsin;AC=MS:1001251	NT=TripleTOF 5600;AC=MS:1000932	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=High-performance liquid chromatography;AC=PRIDE:0000565	NT=HCD;AC=PRIDE:0000590	5 ppm	0.1 Da	30% NCE	RPMI 8226
PXD003539-Sample 29	Homo sapiens	not available	Plasmacytoma	not available	RPMI 8226	1	run 58	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	guot_L130627_005_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130627_005_SW.wiff	2	1	NT=Trypsin;AC=MS:1001251	NT=TripleTOF 5600;AC=MS:1000932	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=High-performance liquid chromatography;AC=PRIDE:0000565	NT=HCD;AC=PRIDE:0000590	5 ppm	0.1 Da	30% NCE	RPMI 8226
PXD003539-Sample 30	Homo sapiens	not available	Breast Cancer	not available	T-47D	1	run 59	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	guot_L130615_006_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130615_006_SW.wiff	1	1	NT=Trypsin;AC=MS:1001251	NT=TripleTOF 5600;AC=MS:1000932	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=High-performance liquid chromatography;AC=PRIDE:0000565	NT=HCD;AC=PRIDE:0000590	5 ppm	0.1 Da	30% NCE	T-47D
PXD003539-Sample 30	Homo sapiens	not available	Breast Cancer	not available	T-47D	1	run 60	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	guot_L130627_006_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130627_006_SW.wiff	2	1	NT=Trypsin;AC=MS:1001251	NT=TripleTOF 5600;AC=MS:1000932	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=High-performance liquid chromatography;AC=PRIDE:0000565	NT=HCD;AC=PRIDE:0000590	5 ppm	0.1 Da	30% NCE	T-47D
PXD003539-Sample 31	Homo sapiens	not available	Lung adenocarcinoma	not available	A549	1	run 61	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	guot_L130616_002_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130616_002_SW.wiff	1	1	NT=Trypsin;AC=MS:1001251	NT=TripleTOF 5600;AC=MS:1000932	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=High-performance liquid chromatography;AC=PRIDE:0000565	NT=HCD;AC=PRIDE:0000590	5 ppm	0.1 Da	30% NCE	A549
PXD003539-Sample 31	Homo sapiens	not available	Lung adenocarcinoma	not available	A549	1	run 62	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	guot_L130628_002_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130628_002_SW.wiff	2	1	NT=Trypsin;AC=MS:1001251	NT=TripleTOF 5600;AC=MS:1000932	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=High-performance liquid chromatography;AC=PRIDE:0000565	NT=HCD;AC=PRIDE:0000590	5 ppm	0.1 Da	30% NCE	A549
PXD003539-Sample 32	Homo sapiens	not available	Breast Cancer	not available	BT-549	1	run 63	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	guot_L130616_003_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130616_003_SW.wiff	1	1	NT=Trypsin;AC=MS:1001251	NT=TripleTOF 5600;AC=MS:1000932	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=High-performance liquid chromatography;AC=PRIDE:0000565	NT=HCD;AC=PRIDE:0000590	5 ppm	0.1 Da	30% NCE	BT-549
PXD003539-Sample 32	Homo sapiens	not available	Breast Cancer	not available	BT-549	1	run 64	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	guot_L130628_003_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130628_003_SW.wiff	2	1	NT=Trypsin;AC=MS:1001251	NT=TripleTOF 5600;AC=MS:1000932	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=High-performance liquid chromatography;AC=PRIDE:0000565	NT=HCD;AC=PRIDE:0000590	5 ppm	0.1 Da	30% NCE	BT-549
PXD003539-Sample 33	Homo sapiens	not available	Non-small cell lung cancer	not available	NCI-H522	1	run 65	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	guot_L130616_004_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130616_004_SW.wiff	1	1	NT=Trypsin;AC=MS:1001251	NT=TripleTOF 5600;AC=MS:1000932	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=High-performance liquid chromatography;AC=PRIDE:0000565	NT=HCD;AC=PRIDE:0000590	5 ppm	0.1 Da	30% NCE	NCI-H522
PXD003539-Sample 33	Homo sapiens	not available	Non-small cell lung cancer	not available	NCI-H522	1	run 66	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	guot_L130628_004_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130628_004_SW.wiff	2	1	NT=Trypsin;AC=MS:1001251	NT=TripleTOF 5600;AC=MS:1000932	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=High-performance liquid chromatography;AC=PRIDE:0000565	NT=HCD;AC=PRIDE:0000590	5 ppm	0.1 Da	30% NCE	NCI-H522
PXD003539-Sample 34	Homo sapiens	not available	Renal Adenocarcinoma	not available	TK10	1	run 67	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	guot_L130616_005_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130616_005_SW.wiff	1	1	NT=Trypsin;AC=MS:1001251	NT=TripleTOF 5600;AC=MS:1000932	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=High-performance liquid chromatography;AC=PRIDE:0000565	NT=HCD;AC=PRIDE:0000590	5 ppm	0.1 Da	30% NCE	TK10
PXD003539-Sample 34	Homo sapiens	not available	Renal Adenocarcinoma	not available	TK10	1	run 68	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	guot_L130628_005_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130628_005_SW.wiff	2	1	NT=Trypsin;AC=MS:1001251	NT=TripleTOF 5600;AC=MS:1000932	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=High-performance liquid chromatography;AC=PRIDE:0000565	NT=HCD;AC=PRIDE:0000590	5 ppm	0.1 Da	30% NCE	TK10
PXD003539-Sample 35	Homo sapiens	not available	Malignant Melanoma	not available	UACC257	1	run 69	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	guot_L130616_006_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130616_006_SW.wiff	1	1	NT=Trypsin;AC=MS:1001251	NT=TripleTOF 5600;AC=MS:1000932	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=High-performance liquid chromatography;AC=PRIDE:0000565	NT=HCD;AC=PRIDE:0000590	5 ppm	0.1 Da	30% NCE	UACC257
PXD003539-Sample 35	Homo sapiens	not available	Malignant Melanoma	not available	UACC257	1	run 70	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	guot_L130628_006_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130628_006_SW.wiff	2	1	NT=Trypsin;AC=MS:1001251	NT=TripleTOF 5600;AC=MS:1000932	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=High-performance liquid chromatography;AC=PRIDE:0000565	NT=HCD;AC=PRIDE:0000590	5 ppm	0.1 Da	30% NCE	UACC257
PXD003539-Sample 36	Homo sapiens	not available	Prostate adenocarcinoma	not available	DU 145	1	run 71	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	guot_L130617_002_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130617_002_SW.wiff	1	1	NT=Trypsin;AC=MS:1001251	NT=TripleTOF 5600;AC=MS:1000932	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=High-performance liquid chromatography;AC=PRIDE:0000565	NT=HCD;AC=PRIDE:0000590	5 ppm	0.1 Da	30% NCE	DU 145
PXD003539-Sample 36	Homo sapiens	not available	Prostate adenocarcinoma	not available	DU 145	1	run 72	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	guot_L130629_002_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130629_002_SW.wiff	2	1	NT=Trypsin;AC=MS:1001251	NT=TripleTOF 5600;AC=MS:1000932	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=High-performance liquid chromatography;AC=PRIDE:0000565	NT=HCD;AC=PRIDE:0000590	5 ppm	0.1 Da	30% NCE	DU 145
PXD003539-Sample 37	Homo sapiens	not available	Colorectal carcinoma	not available	HCT15	1	run 73	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	guot_L130617_003_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130617_003_SW.wiff	1	1	NT=Trypsin;AC=MS:1001251	NT=TripleTOF 5600;AC=MS:1000932	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=High-performance liquid chromatography;AC=PRIDE:0000565	NT=HCD;AC=PRIDE:0000590	5 ppm	0.1 Da	30% NCE	HCT15
PXD003539-Sample 37	Homo sapiens	not available	Colorectal carcinoma	not available	HCT15	1	run 74	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	guot_L130629_003_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130629_003_SW.wiff	2	1	NT=Trypsin;AC=MS:1001251	NT=TripleTOF 5600;AC=MS:1000932	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=High-performance liquid chromatography;AC=PRIDE:0000565	NT=HCD;AC=PRIDE:0000590	5 ppm	0.1 Da	30% NCE	HCT15
PXD003539-Sample 38	Homo sapiens	not available	Acute lymphoblastic leukemia ALL	not available	MOLT-4	1	run 75	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	guot_L130617_004_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130617_004_SW.wiff	1	1	NT=Trypsin;AC=MS:1001251	NT=TripleTOF 5600;AC=MS:1000932	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=High-performance liquid chromatography;AC=PRIDE:0000565	NT=HCD;AC=PRIDE:0000590	5 ppm	0.1 Da	30% NCE	MOLT-4
PXD003539-Sample 38	Homo sapiens	not available	Acute lymphoblastic leukemia ALL	not available	MOLT-4	1	run 76	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	guot_L130629_004_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130629_004_SW.wiff	2	1	NT=Trypsin;AC=MS:1001251	NT=TripleTOF 5600;AC=MS:1000932	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=High-performance liquid chromatography;AC=PRIDE:0000565	NT=HCD;AC=PRIDE:0000590	5 ppm	0.1 Da	30% NCE	MOLT-4
PXD003539-Sample 39	Homo sapiens	not available	Lung adenocarcinoma	not available	NCI-H460	1	run 77	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	guot_L130617_005_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130617_005_SW.wiff	1	1	NT=Trypsin;AC=MS:1001251	NT=TripleTOF 5600;AC=MS:1000932	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=High-performance liquid chromatography;AC=PRIDE:0000565	NT=HCD;AC=PRIDE:0000590	5 ppm	0.1 Da	30% NCE	NCI-H460
PXD003539-Sample 39	Homo sapiens	not available	Lung adenocarcinoma	not available	NCI-H460	1	run 78	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	guot_L130629_005_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130629_005_SW.wiff	2	1	NT=Trypsin;AC=MS:1001251	NT=TripleTOF 5600;AC=MS:1000932	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=High-performance liquid chromatography;AC=PRIDE:0000565	NT=HCD;AC=PRIDE:0000590	5 ppm	0.1 Da	30% NCE	NCI-H460
PXD003539-Sample 40	Homo sapiens	not available	Brain Cancer	not available	U251	1	run 79	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	guot_L130617_006_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130617_006_SW.wiff	1	1	NT=Trypsin;AC=MS:1001251	NT=TripleTOF 5600;AC=MS:1000932	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=High-performance liquid chromatography;AC=PRIDE:0000565	NT=HCD;AC=PRIDE:0000590	5 ppm	0.1 Da	30% NCE	U251
PXD003539-Sample 40	Homo sapiens	not available	Brain Cancer	not available	U251	1	run 80	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	guot_L130629_006_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130629_006_SW.wiff	2	1	NT=Trypsin;AC=MS:1001251	NT=TripleTOF 5600;AC=MS:1000932	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=High-performance liquid chromatography;AC=PRIDE:0000565	NT=HCD;AC=PRIDE:0000590	5 ppm	0.1 Da	30% NCE	U251
PXD003539-Sample 41	Homo sapiens	not available	Colorectal carcinoma	not available	COLO 205	1	run 81	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	guot_L130618_002_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130618_002_SW.wiff	1	1	NT=Trypsin;AC=MS:1001251	NT=TripleTOF 5600;AC=MS:1000932	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=High-performance liquid chromatography;AC=PRIDE:0000565	NT=HCD;AC=PRIDE:0000590	5 ppm	0.1 Da	30% NCE	COLO 205
PXD003539-Sample 41	Homo sapiens	not available	Colorectal carcinoma	not available	COLO 205	1	run 82	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	guot_L130630_002_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130630_002_SW.wiff	2	1	NT=Trypsin;AC=MS:1001251	NT=TripleTOF 5600;AC=MS:1000932	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=High-performance liquid chromatography;AC=PRIDE:0000565	NT=HCD;AC=PRIDE:0000590	5 ppm	0.1 Da	30% NCE	COLO 205
PXD003539-Sample 42	Homo sapiens	not available	Breast Cancer	not available	MDA-MB-468	1	run 83	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	guot_L130618_003_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130618_003_SW.wiff	1	1	NT=Trypsin;AC=MS:1001251	NT=TripleTOF 5600;AC=MS:1000932	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=High-performance liquid chromatography;AC=PRIDE:0000565	NT=HCD;AC=PRIDE:0000590	5 ppm	0.1 Da	30% NCE	MDA-MB-468
PXD003539-Sample 42	Homo sapiens	not available	Breast Cancer	not available	MDA-MB-468	1	run 84	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	guot_L130630_003_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130630_003_SW.wiff	2	1	NT=Trypsin;AC=MS:1001251	NT=TripleTOF 5600;AC=MS:1000932	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=High-performance liquid chromatography;AC=PRIDE:0000565	NT=HCD;AC=PRIDE:0000590	5 ppm	0.1 Da	30% NCE	MDA-MB-468
PXD003539-Sample 43	Homo sapiens	not available	Lung adenocarcinoma	not available	NCI-H226	1	run 85	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	guot_L130618_004_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130618_004_SW.wiff	1	1	NT=Trypsin;AC=MS:1001251	NT=TripleTOF 5600;AC=MS:1000932	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=High-performance liquid chromatography;AC=PRIDE:0000565	NT=HCD;AC=PRIDE:0000590	5 ppm	0.1 Da	30% NCE	NCI-H226
PXD003539-Sample 43	Homo sapiens	not available	Lung adenocarcinoma	not available	NCI-H226	1	run 86	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	guot_L130630_004_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130630_004_SW.wiff	2	1	NT=Trypsin;AC=MS:1001251	NT=TripleTOF 5600;AC=MS:1000932	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=High-performance liquid chromatography;AC=PRIDE:0000565	NT=HCD;AC=PRIDE:0000590	5 ppm	0.1 Da	30% NCE	NCI-H226
PXD003539-Sample 44	Homo sapiens	not available	Ovarian Cancer	not available	OVCAR3	1	run 87	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	guot_L130618_005_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130618_005_SW.wiff	1	1	NT=Trypsin;AC=MS:1001251	NT=TripleTOF 5600;AC=MS:1000932	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=High-performance liquid chromatography;AC=PRIDE:0000565	NT=HCD;AC=PRIDE:0000590	5 ppm	0.1 Da	30% NCE	OVCAR3
PXD003539-Sample 44	Homo sapiens	not available	Ovarian Cancer	not available	OVCAR3	1	run 88	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	guot_L130630_005_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130630_005_SW.wiff	2	1	NT=Trypsin;AC=MS:1001251	NT=TripleTOF 5600;AC=MS:1000932	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=High-performance liquid chromatography;AC=PRIDE:0000565	NT=HCD;AC=PRIDE:0000590	5 ppm	0.1 Da	30% NCE	OVCAR3
PXD003539-Sample 45	Homo sapiens	not available	Brain Cancer	not available	SF268	1	run 89	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	guot_L130618_006_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130618_006_SW.wiff	1	1	NT=Trypsin;AC=MS:1001251	NT=TripleTOF 5600;AC=MS:1000932	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=High-performance liquid chromatography;AC=PRIDE:0000565	NT=HCD;AC=PRIDE:0000590	5 ppm	0.1 Da	30% NCE	SF268
PXD003539-Sample 45	Homo sapiens	not available	Brain Cancer	not available	SF268	1	run 90	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	guot_L130630_006_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130630_006_SW.wiff	2	1	NT=Trypsin;AC=MS:1001251	NT=TripleTOF 5600;AC=MS:1000932	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=High-performance liquid chromatography;AC=PRIDE:0000565	NT=HCD;AC=PRIDE:0000590	5 ppm	0.1 Da	30% NCE	SF268
PXD003539-Sample 46	Homo sapiens	not available	Colon adenocarcinoma?	not available	HCC2998	1	run 91	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	guot_L130619_002_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130619_002_SW.wiff	1	1	NT=Trypsin;AC=MS:1001251	NT=TripleTOF 5600;AC=MS:1000932	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=High-performance liquid chromatography;AC=PRIDE:0000565	NT=HCD;AC=PRIDE:0000590	5 ppm	0.1 Da	30% NCE	HCC2998
PXD003539-Sample 46	Homo sapiens	not available	Colon adenocarcinoma?	not available	HCC2998	1	run 92	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	guot_L130701_002_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130701_002_SW.wiff	2	1	NT=Trypsin;AC=MS:1001251	NT=TripleTOF 5600;AC=MS:1000932	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=High-performance liquid chromatography;AC=PRIDE:0000565	NT=HCD;AC=PRIDE:0000590	5 ppm	0.1 Da	30% NCE	HCC2998
PXD003539-Sample 47	Homo sapiens	not available	Malignant Melanoma	not available	MDA-MB-435	1	run 93	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	guot_L130619_003_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130619_003_SW.wiff	1	1	NT=Trypsin;AC=MS:1001251	NT=TripleTOF 5600;AC=MS:1000932	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=High-performance liquid chromatography;AC=PRIDE:0000565	NT=HCD;AC=PRIDE:0000590	5 ppm	0.1 Da	30% NCE	MDA-MB-435
PXD003539-Sample 47	Homo sapiens	not available	Malignant Melanoma	not available	MDA-MB-435	1	run 94	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	guot_L130701_003_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130701_003_SW.wiff	2	1	NT=Trypsin;AC=MS:1001251	NT=TripleTOF 5600;AC=MS:1000932	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=High-performance liquid chromatography;AC=PRIDE:0000565	NT=HCD;AC=PRIDE:0000590	5 ppm	0.1 Da	30% NCE	MDA-MB-435
PXD003539-Sample 48	Homo sapiens	not available	Ovarian Cancer	not available	NCI-ADR-RES	1	run 95	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	guot_L130619_004_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130619_004_SW.wiff	1	1	NT=Trypsin;AC=MS:1001251	NT=TripleTOF 5600;AC=MS:1000932	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=High-performance liquid chromatography;AC=PRIDE:0000565	NT=HCD;AC=PRIDE:0000590	5 ppm	0.1 Da	30% NCE	NCI-ADR-RES
PXD003539-Sample 48	Homo sapiens	not available	Ovarian Cancer	not available	NCI-ADR-RES	1	run 96	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	guot_L130701_004_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130701_004_SW.wiff	2	1	NT=Trypsin;AC=MS:1001251	NT=TripleTOF 5600;AC=MS:1000932	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=High-performance liquid chromatography;AC=PRIDE:0000565	NT=HCD;AC=PRIDE:0000590	5 ppm	0.1 Da	30% NCE	NCI-ADR-RES
PXD003539-Sample 49	Homo sapiens	not available	Non-small cell lung cancer	not available	NCI-H23	1	run 97	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	guot_L130619_005_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130619_005_SW.wiff	1	1	NT=Trypsin;AC=MS:1001251	NT=TripleTOF 5600;AC=MS:1000932	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=High-performance liquid chromatography;AC=PRIDE:0000565	NT=HCD;AC=PRIDE:0000590	5 ppm	0.1 Da	30% NCE	NCI-H23
PXD003539-Sample 49	Homo sapiens	not available	Non-small cell lung cancer	not available	NCI-H23	1	run 98	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	guot_L130701_005_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130701_005_SW.wiff	2	1	NT=Trypsin;AC=MS:1001251	NT=TripleTOF 5600;AC=MS:1000932	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=High-performance liquid chromatography;AC=PRIDE:0000565	NT=HCD;AC=PRIDE:0000590	5 ppm	0.1 Da	30% NCE	NCI-H23
PXD003539-Sample 50	Homo sapiens	not available	Renal Adenocarcinoma	not available	UO31	1	run 99	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	guot_L130619_006_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130619_006_SW.wiff	1	1	NT=Trypsin;AC=MS:1001251	NT=TripleTOF 5600;AC=MS:1000932	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=High-performance liquid chromatography;AC=PRIDE:0000565	NT=HCD;AC=PRIDE:0000590	5 ppm	0.1 Da	30% NCE	UO31
PXD003539-Sample 50	Homo sapiens	not available	Renal Adenocarcinoma	not available	UO31	1	run 100	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	guot_L130701_006_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130701_006_SW.wiff	2	1	NT=Trypsin;AC=MS:1001251	NT=TripleTOF 5600;AC=MS:1000932	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=High-performance liquid chromatography;AC=PRIDE:0000565	NT=HCD;AC=PRIDE:0000590	5 ppm	0.1 Da	30% NCE	UO31
PXD003539-Sample 51	Homo sapiens	not available	Lung adenocarcinoma	not available	HOP62	1	run 101	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	guot_L130620_002_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130620_002_SW.wiff	1	1	NT=Trypsin;AC=MS:1001251	NT=TripleTOF 5600;AC=MS:1000932	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=High-performance liquid chromatography;AC=PRIDE:0000565	NT=HCD;AC=PRIDE:0000590	5 ppm	0.1 Da	30% NCE	HOP62
PXD003539-Sample 51	Homo sapiens	not available	Lung adenocarcinoma	not available	HOP62	1	run 102	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	guot_L130702_002_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130702_002_SW.wiff	2	1	NT=Trypsin;AC=MS:1001251	NT=TripleTOF 5600;AC=MS:1000932	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=High-performance liquid chromatography;AC=PRIDE:0000565	NT=HCD;AC=PRIDE:0000590	5 ppm	0.1 Da	30% NCE	HOP62
PXD003539-Sample 52	Homo sapiens	not available	Breast Cancer	not available	Hs 578T	1	run 103	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	guot_L130722_001_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130722_001_SW.wiff	1	1	NT=Trypsin;AC=MS:1001251	NT=TripleTOF 5600;AC=MS:1000932	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=High-performance liquid chromatography;AC=PRIDE:0000565	NT=HCD;AC=PRIDE:0000590	5 ppm	0.1 Da	30% NCE	Hs 578T
PXD003539-Sample 52	Homo sapiens	not available	Breast Cancer	not available	Hs 578T	1	run 104	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	guot_L130722_002_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130722_002_SW.wiff	2	1	NT=Trypsin;AC=MS:1001251	NT=TripleTOF 5600;AC=MS:1000932	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=High-performance liquid chromatography;AC=PRIDE:0000565	NT=HCD;AC=PRIDE:0000590	5 ppm	0.1 Da	30% NCE	Hs 578T
PXD003539-Sample 53	Homo sapiens	not available	Malignant Melanoma	not available	M14	1	run 105	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	guot_L130722_003_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130722_003_SW.wiff	1	1	NT=Trypsin;AC=MS:1001251	NT=TripleTOF 5600;AC=MS:1000932	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=High-performance liquid chromatography;AC=PRIDE:0000565	NT=HCD;AC=PRIDE:0000590	5 ppm	0.1 Da	30% NCE	M14
PXD003539-Sample 53	Homo sapiens	not available	Malignant Melanoma	not available	M14	1	run 106	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	guot_L130722_004_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130722_004_SW.wiff	2	1	NT=Trypsin;AC=MS:1001251	NT=TripleTOF 5600;AC=MS:1000932	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=High-performance liquid chromatography;AC=PRIDE:0000565	NT=HCD;AC=PRIDE:0000590	5 ppm	0.1 Da	30% NCE	M14
PXD003539-Sample 54	Homo sapiens	not available	Ovarian Cancer	not available	OVCAR-5	1	run 107	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	guot_L130620_005_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130620_005_SW.wiff	1	1	NT=Trypsin;AC=MS:1001251	NT=TripleTOF 5600;AC=MS:1000932	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=High-performance liquid chromatography;AC=PRIDE:0000565	NT=HCD;AC=PRIDE:0000590	5 ppm	0.1 Da	30% NCE	OVCAR-5
PXD003539-Sample 54	Homo sapiens	not available	Ovarian Cancer	not available	OVCAR-5	1	run 108	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	guot_L130702_005_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130702_005_SW.wiff	2	1	NT=Trypsin;AC=MS:1001251	NT=TripleTOF 5600;AC=MS:1000932	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=High-performance liquid chromatography;AC=PRIDE:0000565	NT=HCD;AC=PRIDE:0000590	5 ppm	0.1 Da	30% NCE	OVCAR-5
PXD003539-Sample 55	Homo sapiens	not available	Large Cell Immunoblastic Lymphoma	not available	SR	1	run 109	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	guot_L130620_006_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130620_006_SW.wiff	1	1	NT=Trypsin;AC=MS:1001251	NT=TripleTOF 5600;AC=MS:1000932	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=High-performance liquid chromatography;AC=PRIDE:0000565	NT=HCD;AC=PRIDE:0000590	5 ppm	0.1 Da	30% NCE	SR
PXD003539-Sample 55	Homo sapiens	not available	Large Cell Immunoblastic Lymphoma	not available	SR	1	run 110	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	guot_L130702_006_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130702_006_SW.wiff	2	1	NT=Trypsin;AC=MS:1001251	NT=TripleTOF 5600;AC=MS:1000932	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=High-performance liquid chromatography;AC=PRIDE:0000565	NT=HCD;AC=PRIDE:0000590	5 ppm	0.1 Da	30% NCE	SR
PXD003539-Sample 56	Homo sapiens	not available	Lung adenocarcinoma	not available	HOP92	1	run 111	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	guot_L130621_002_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130621_002_SW.wiff	1	1	NT=Trypsin;AC=MS:1001251	NT=TripleTOF 5600;AC=MS:1000932	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=High-performance liquid chromatography;AC=PRIDE:0000565	NT=HCD;AC=PRIDE:0000590	5 ppm	0.1 Da	30% NCE	HOP92
PXD003539-Sample 56	Homo sapiens	not available	Lung adenocarcinoma	not available	HOP92	1	run 112	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	guot_L130703_002_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130703_002_SW.wiff	2	1	NT=Trypsin;AC=MS:1001251	NT=TripleTOF 5600;AC=MS:1000932	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=High-performance liquid chromatography;AC=PRIDE:0000565	NT=HCD;AC=PRIDE:0000590	5 ppm	0.1 Da	30% NCE	HOP92
PXD003539-Sample 57	Homo sapiens	not available	Malignant Melanoma	not available	LOX-IMVI	1	run 113	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	guot_L130621_003_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130621_003_SW.wiff	1	1	NT=Trypsin;AC=MS:1001251	NT=TripleTOF 5600;AC=MS:1000932	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=High-performance liquid chromatography;AC=PRIDE:0000565	NT=HCD;AC=PRIDE:0000590	5 ppm	0.1 Da	30% NCE	LOX-IMVI
PXD003539-Sample 57	Homo sapiens	not available	Malignant Melanoma	not available	LOX-IMVI	1	run 114	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	guot_L130703_003b_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130703_003b_SW.wiff	2	1	NT=Trypsin;AC=MS:1001251	NT=TripleTOF 5600;AC=MS:1000932	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=High-performance liquid chromatography;AC=PRIDE:0000565	NT=HCD;AC=PRIDE:0000590	5 ppm	0.1 Da	30% NCE	LOX-IMVI
PXD003539-Sample 58	Homo sapiens	not available	Prostate adenocarcinoma	not available	PC-3	1	run 115	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	guot_L130621_004_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130621_004_SW.wiff	1	1	NT=Trypsin;AC=MS:1001251	NT=TripleTOF 5600;AC=MS:1000932	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=High-performance liquid chromatography;AC=PRIDE:0000565	NT=HCD;AC=PRIDE:0000590	5 ppm	0.1 Da	30% NCE	PC-3
PXD003539-Sample 58	Homo sapiens	not available	Prostate adenocarcinoma	not available	PC-3	1	run 116	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	guot_L130703_004_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130703_004_SW.wiff	2	1	NT=Trypsin;AC=MS:1001251	NT=TripleTOF 5600;AC=MS:1000932	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=High-performance liquid chromatography;AC=PRIDE:0000565	NT=HCD;AC=PRIDE:0000590	5 ppm	0.1 Da	30% NCE	PC-3
PXD003539-Sample 59	Homo sapiens	not available	Renal Adenocarcinoma	not available	SN12C	1	run 117	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	guot_L130621_005_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130621_005_SW.wiff	1	1	NT=Trypsin;AC=MS:1001251	NT=TripleTOF 5600;AC=MS:1000932	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=High-performance liquid chromatography;AC=PRIDE:0000565	NT=HCD;AC=PRIDE:0000590	5 ppm	0.1 Da	30% NCE	SN12C
PXD003539-Sample 59	Homo sapiens	not available	Renal Adenocarcinoma	not available	SN12C	1	run 118	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	guot_L130703_005_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130703_005_SW.wiff	2	1	NT=Trypsin;AC=MS:1001251	NT=TripleTOF 5600;AC=MS:1000932	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=High-performance liquid chromatography;AC=PRIDE:0000565	NT=HCD;AC=PRIDE:0000590	5 ppm	0.1 Da	30% NCE	SN12C
PXD003539-Sample 60	Homo sapiens	not available	Brain Cancer	not available	SNB75	1	run 119	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	guot_L130719_002_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130719_002_SW.wiff	1	1	NT=Trypsin;AC=MS:1001251	NT=TripleTOF 5600;AC=MS:1000932	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=High-performance liquid chromatography;AC=PRIDE:0000565	NT=HCD;AC=PRIDE:0000590	5 ppm	0.1 Da	30% NCE	SNB75
PXD003539-Sample 60	Homo sapiens	not available	Brain Cancer	not available	SNB75	1	run 120	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	guot_L130719_003_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130719_003_SW.wiff	2	1	NT=Trypsin;AC=MS:1001251	NT=TripleTOF 5600;AC=MS:1000932	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=High-performance liquid chromatography;AC=PRIDE:0000565	NT=HCD;AC=PRIDE:0000590	5 ppm	0.1 Da	30% NCE	SNB75
